In this newly created position, Dr. Rose will work to foster innovation and commercialization opportunities for investigators throughout the Department of Medicine in a collaboration with UPMC Enterprises and the University of Pittsburgh.

In this role, she will support the use of real-world evidence in health research by facilitating access to data and nurturing partnerships with industry partnerships to support research undertaken by DOM clinicians and researchers.

Professor of Medicine in the Division of Rheumatology and Clinical Immunology, Dr. Sarah Gaffen is an international expert on IL-17 and its role in autoimmune diseases. She is one of only four Pitt faculty to be elected to the AAAS this year.

The grant will allow Dr. Chan and Co-PI Dr. Colleen McClung to study the genetic underpinnings of sleep dysfunction.

Based on results from the KEYNOTE-716 trial led by Dr. Jason Luke, pembrolizumab resulted in a marked improvement in recurrence-free survival (RFS) and reduced disease recurrence or death by 35%, leading to its approval for treatment of patients 12 years and older...

Led by Drs. Toren Finkel and Melanie Königshoff, the TriState SenNet TMC combines the expertise of faculty from Pitt, CMU, OSU, and URMC to develop a high-resolution map of the senescent cell population in the human lung and heart, define the physiological drivers of senescence, and provide a rational approach to understand the therapeutic potential of senolytic therapy.

To better understand potential damage that emerging vaping products may have on human lungs, Dr. Benam and his team have created a first-in-kind biologically inspired robotic system that quantitatively analyzes submicron and microparticles generated from electronic cigarettes in real-time while mimicking clinically relevant breathing and vaping topography exactly as happens in humans.